Interventional Cardiology, Division of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
EuroIntervention. 2017 May 15;13(Z):Z32-Z36. doi: 10.4244/EIJ-D-16-00835.
The Israel Heart Society is a member of the European Society of Cardiology, and the Israeli Working Group of Interventional Cardiology is an active participant in EAPCI. The aim of this manuscript is to provide a snapshot of cardiac interventions performed in the State of Israel during the period 2010-2015. Data for this manuscript were collected via collaboration with the National Diseases Registries Unit of the Israel Center for Disease Control. During the survey period, the Israeli population increased by 7% but only one additional hospital with an active cardiac catheterisation laboratory was opened. The vast majority of the percutaneous procedures are performed in public hospital settings. Total coronary angiography procedures remained stable throughout the survey period, and the percentage of PCI out of total coronary angiography procedures remained approximately 50% throughout the survey period. More than 90% of the PCI procedures were performed using stent deployment, and the use of drug-eluting stents increased significantly during the survey period from 46% in 2010 to 92% in 2015. The number of TAVI procedures increased dramatically, by more than sixfold, from 130 procedures in 2010 to 851 procedures in 2015 (with 130 implants/million population at Q4 of 2015). The vast majority of interventional cardiology procedures are funded by the governmental healthcare providers, and all the citizens of the country have access to the most advanced cardiac interventions. If corrected for the increase in the population, the volumes of coronary interventions are decreasing throughout the country. However, structural heart disease interventions, and specifically valvular interventions, are growing rapidly and this trend is expected to continue in the near future.
以色列心脏学会是欧洲心脏病学会的成员,以色列介入心脏病学工作组是 EAPCI 的积极参与者。本文旨在提供 2010-2015 年期间在以色列进行的心脏介入治疗的概况。本文的数据是通过与以色列疾病控制中心国家疾病登记处的合作收集的。在调查期间,以色列人口增长了 7%,但仅增加了一家开设心脏导管实验室的医院。绝大多数经皮手术都是在公立医院进行的。整个调查期间,冠状动脉造影术的总数保持稳定,而经皮冠状动脉介入治疗术(PCI)占冠状动脉造影术的比例在整个调查期间保持在约 50%。超过 90%的 PCI 手术采用支架置入术,药物洗脱支架的使用率在调查期间显著增加,从 2010 年的 46%增加到 2015 年的 92%。经导管主动脉瓣置换术(TAVI)的数量急剧增加,从 2010 年的 130 例增加到 2015 年的 851 例(2015 年第四季度每百万人中有 130 例植入)。绝大多数介入心脏病学手术由政府医疗保健提供者提供资金,该国所有公民都可以获得最先进的心脏介入治疗。如果根据人口增长进行校正,全国的冠状动脉介入数量正在减少。然而,结构性心脏病介入治疗,特别是瓣膜介入治疗,正在迅速增长,这种趋势预计在不久的将来将继续。